This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
5 Defensive ETF Areas to Consider Amid Current Market Meltdown
by Sweta Jaiswal, FRM
Let's check out a few safe ETF areas that investors can consider keeping in mind the rising concerns from the high inflation levels amid the war crisis.
The Zacks Analyst Blog Highlights iShares U.S. Healthcare ETF, The Financial Select Sector SPDR Fund, Invesco S&P 500 Enhanced Value ETF, WisdomTree U.S. Quality Dividend Growth Fund and Global X Cloud Computing ETF
by Zacks Equity Research
iShares U.S. Healthcare ETF, The Financial Select Sector SPDR Fund, Invesco S&P 500 Enhanced Value ETF, WisdomTree U.S. Quality Dividend Growth Fund and Global X Cloud Computing ETF have been included in this Analyst Blog.
5 Top-Ranked ETFs Looking Great Bets Now
by Sweta Jaiswal, FRM
Against the backdrop of the existent investing space, let's save some top-ranked ETFs for a rainy day.
Bet on These 2 ETF Areas Amid Current Market Rout
by Sweta Jaiswal, FRM
Let's look at the two ETF areas that can be good investment options: one benefits from the tightening demand-supply conditions` in the crude oil market while the other is a defensive bet.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
5 Top-Ranked ETFs That Can be Great Bets Now
by Sweta Jaiswal, FRM
Considering the current investing environment, let's take a glance at some top-ranked ETFs that investors can consider.
Healthcare ETFs in Focus Ahead of Q1 Earnings
by Sweta Killa
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfolio.
Healthcare ETFs to Gain on UnitedHealth's Solid Q1 Earnings
by Sweta Killa
UnitedHealth reported better-than-expected first-quarter 2020 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance.
Healthcare ETFs Outperform Amid Rising Uncertainties
by Neena Mishra
Investors are seeking refuge in healthcare stocks as inflation and rates rise
Healthcare ETFs Gaining Attention Amid Rising Market Tensions
by Sweta Jaiswal, FRM
Let's take a look at some healthcare ETFs that are regaining popularity among investors as COVID-19 cases rise in China and market uncertainties increase.
China's COVID-19 Lockdown Brings Back Focus on Healthcare ETFs
by Sweta Jaiswal, FRM
Let's take a look at some healthcare ETFs that are regaining popularity among investors as COVID-19 cases rise in China.
UnitedHealth's Solid Q4 Earnings Put These ETFs in Focus
by Sweta Killa
Investors could tap this opportune moment with ETFs having the largest allocation to UnitedHealth.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
5 Top-Ranked ETF Making Great Investment Options for November
by Sweta Jaiswal, FRM
Take a look at some top-ranked ETFs that might help strengthen your portfolio and rake in some good returns.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
Healthcare ETFs in Focus as Q3 Earnings Unfold
by Sweta Killa
The healthcare sector is expected to witness substantial earnings growth of 17.5% in the third quarter.
JNJ Posts Mixed Q3 Bag, Ups View: ETFs in Focus
by Sweta Killa
Johnson & Johnson (JNJ) continued its long streak of earnings beat but lagged the revenue estimates. The company lifted its full-year guidance.
4 Defensive Sector ETFs to Protect Your Portfolio
by Sweta Killa
A myriad of concerns has made investors jittery, resulting in a flight to defensive sectors like utilities, real estate, healthcare and consumer staples.
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
by Sweta Jaiswal, FRM
The positive data update has put the spotlight on a number of ETFs that could benefit from their high exposure to Johnson & Johnson.
5 ETF Areas for Investors to Consider Amid the September Slump
by Sweta Jaiswal, FRM
Amid the market uncertainty, we have highlighted some ETF areas that can be good investment options for market participants to combat the September chaos.
Climb the "Wall of Worry" With These ETFs
by Sweta Killa
A myriad of hurdles has continued to kept investors jittery and resulted in a flight to defensive sectors like utilities, real estate, healthcare and consumer staples.
Time for Pharma and Healthcare ETFs?
by Sanghamitra Saha
The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales
2 Sector ETFs Hovering Around All-Time Highs
by Sanghamitra Saha
The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.
Healthcare ETFs in Focus as Q2 Earnings Unfold
by Sweta Killa
The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.